Prof. Dr. Raja Atreya

Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s (2018) Binder MT, Becker E, Wiendl M, Schleier L, Fuchs F, Leppkes M, Atreya R, et al. Journal article Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study (2018) Panaccione R, Atreya R, Ferrante M, Dubinsky MC, Sands BE, Abreu MT, Cataldi F, et al. Conference contribution Molecular imaging within the lower gastrointestinal tract: From feasibility to future (2018) Rath T, Kiesslich R, Neurath M, Atreya R Journal article Molecular imaging in gastroenterology: A route for personalized endoscopy (2018) Klenske E, Neurath M, Atreya R, Rath T Journal article Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study (2018) Görtz R, Klett D, Wildner D, Atreya R, Neurath M, Strobel D Journal article Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study (2018) Tontini GE, Mudter J, Günther C, Milani V, Atreya R, Rath T, Nagel A, et al. Journal article Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018) Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al. Conference contribution Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018) Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al. Conference contribution